Hormone replacement therapy and endometrial cancer risk: a meta-analysis.

[1]  L. Hedges,et al.  The Handbook of Research Synthesis , 1995 .

[2]  J. Woodruff,et al.  Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group. , 1994, American journal of obstetrics and gynecology.

[3]  D. Kiel,et al.  The effect of postmenopausal estrogen therapy on bone density in elderly women. , 1993, The New England journal of medicine.

[4]  Brinton La,et al.  Estrogen Replacement Therapy and Endometrial Cancer Risk: Unresolved Issues , 1993, Obstetrics and gynecology.

[5]  A. Walker,et al.  Estrogens, Progesterone, and Endometrial Cancer , 1993, Epidemiology.

[6]  C. la Vecchia,et al.  Oestrogen replacement treatment and the risk of endometrial cancer: an assessment of the role of covariates. , 1993, European journal of cancer.

[7]  Caroline S. Fox,et al.  Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women , 1992, Annals of Internal Medicine.

[8]  S. Shapiro,et al.  Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study. , 1991, American journal of epidemiology.

[9]  G. Belle,et al.  Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer , 1991, The Lancet.

[10]  K. McPherson,et al.  Mortality in a cohort of long‐term users of hormone replacement therapy: an updated analysis , 1990 .

[11]  J. Gallagher,et al.  Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient. , 1990, American journal of obstetrics and gynecology.

[12]  M. Whitehead,et al.  The Role and Use of Progestogens , 1990, Obstetrics and gynecology.

[13]  E. Guzman,et al.  A quantitative analysis of placental vasculature in the third‐trimester fetus with autosomal trisomy , 1990, Obstetrics and gynecology.

[14]  P. Wingo,et al.  Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies. , 1990 .

[15]  R. Hoover,et al.  Risk of cancer in women receiving hormone replacement therapy , 1989, International journal of cancer.

[16]  A. Ferenczy,et al.  A Prospective 1-Year Study of Estrogen and Progestin in Postmenopausal Women: Effects on the Endometrium , 1989, Obstetrics and gynecology.

[17]  B. Henderson,et al.  Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study. , 1989, British Journal of Cancer.

[18]  R. Hoover,et al.  Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. , 1989, BMJ.

[19]  B. Ettinger,et al.  Gynecologic consequences of long-term, unopposed estrogen replacement therapy. , 1988, Maturitas.

[20]  H. Adami,et al.  Risk factors for breast and endometrial cancer in a cohort of women treated with menopausal oestrogens. , 1988, International journal of epidemiology.

[21]  M. Ewertz,et al.  The joint effect of risk factors on endometrial cancer. , 1988, European journal of cancer & clinical oncology.

[22]  B. Hulka.  Replacement estrogens and risk of gynecologic cancers and breast cancer , 1987, Cancer.

[23]  S. Sidney,et al.  Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. , 1987, Obstetrics and gynecology.

[24]  M. Coleman,et al.  Long‐term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy , 1987 .

[25]  M. Whitehead,et al.  The effects of estrogens and progestogens on the endometrium. Modern approach to treatment. , 1987, Obstetrics and gynecology clinics of North America.

[26]  S Greenland,et al.  Quantitative methods in the review of epidemiologic literature. , 1987, Epidemiologic reviews.

[27]  A. Feinstein,et al.  Estrogens and endometrial cancer. Responses to arguments and current status of an epidemiologic controversy. , 1986, The American journal of medicine.

[28]  C. Bain,et al.  Conjugated estrogen use and risk of endometrial cancer. , 1986, American journal of epidemiology.

[29]  R. Gambrell.  Prevention of endometrial cancer with progestogens. , 1986, Maturitas.

[30]  G. Eklund,et al.  The Risk of Endometrial Neoplasia and Treatment with Estrogens and Estrogen ‐ Progestogen Combinations: First results of a cohort study after one to four completed years of observation , 1986, Acta obstetricia et gynecologica Scandinavica.

[31]  S. Shapiro,et al.  Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens. , 1985, The New England journal of medicine.

[32]  F. Lafferty,et al.  Post-menopausal estrogen replacement: the prevention of osteoporosis and systemic effects. , 1985, Maturitas.

[33]  J. Studd,et al.  Amenorrhea and Endometrial Atrophy With Continuous Oral Estrogen and Progestogen Therapy in Postmenopausal Women , 1985, Obstetrics and gynecology.

[34]  Gambrell Rd.  Hormones in the etiology and prevention of breast and endometrial cancer. , 1984 .

[35]  R. Gambrell.  Proposal to decrease the risk and improve the prognosis of breast cancer. , 1984, American journal of obstetrics and gynecology.

[36]  C. la Vecchia,et al.  Risk factors for endometrial cancer at different ages. , 1984, Journal of the National Cancer Institute.

[37]  P. Stolley,et al.  Comparison of Estrogen‐Induced Hyperplasia to Endometrial Carcinoma , 1984, Obstetrics and Gynecology.

[38]  M. Pike,et al.  The epidemiology of endometrial cancer in young women. , 1983, British Journal of Cancer.

[39]  R. W. Morgan,et al.  Exogenous estrogens and development of breast and endometrial cancer. , 1983, Cancer detection and prevention.

[40]  Gambrell Rd.  Clinical use of progestins in the menopausal patient: dosage and duration. , 1982 .

[41]  J. Kelsey,et al.  A case-control study of cancer of the endometrium. , 1982, American journal of epidemiology.

[42]  N. Siddle,et al.  Effects of various types and dosages of progestogens on the postmenopausal endometrium. , 1982, The Journal of reproductive medicine.

[43]  N. Weiss,et al.  Survival among women with endometrial cancer: a comparison of estrogen users and nonusers. , 1982, American journal of obstetrics and gynecology.

[44]  D. Cramer,et al.  Endometrial hyperplasia in women on cyclic or continuous estrogen regimens. , 1982, Fertility and sterility.

[45]  R. Gambrell.  Role of Hormones in the Etiology and Prevention of Endometrial and Breast Cancer , 1982, Acta obstetricia et gynecologica Scandinavica. Supplement.

[46]  R. Spengler,et al.  Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases. , 1981, American journal of epidemiology.

[47]  A. Donner,et al.  A comparison of estrogen use by women with endometrial cancer, gynecologic disorders, and other illnesses. , 1981, American journal of obstetrics and gynecology.

[48]  L. Allen,et al.  ŒSTROGEN USE AND SURVIVAL IN ENDOMETRIAL CANCER , 1980, The Lancet.

[49]  R. Gambrell,et al.  Use of the Progestogen Challenge Test to Reduce the Risk of Endometrial Cancer , 1980, Obstetrics and gynecology.

[50]  W. Creasman,et al.  Risk of exogenous estrogen therapy and endometrial cancer. , 1980, American journal of obstetrics and gynecology.

[51]  C. C. Pulliam,et al.  Estrogen and endometrial cancer: cases and two control groups from North Carolina. , 1980, American journal of obstetrics and gynecology.

[52]  T. Salmi.  Endometrial carcinoma risk factors, with special reference to the use of oestrogens. , 1980, Acta endocrinologica. Supplementum.

[53]  J. Studd,et al.  PREVENTION AND TREATMENT OF ENDOMETRIAL DISEASE IN CLIMACTERIC WOMEN RECEIVING ŒSTROGEN THERAPY , 1979, The Lancet.

[54]  S. Robboy,et al.  Changing Trends and Prognostic Features in Endometrial Cancer Associated with Exogenous Estrogen Therapy , 1979, Obstetrics and gynecology.

[55]  D. English,et al.  Endometrial cancer in relation to patterns of menopausal estrogen use. , 1979, JAMA.

[56]  E. Beckman,et al.  Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. , 1979, Obstetrics and gynecology.

[57]  W. Creasman,et al.  Effects of long-term estrogen replacement therapy: II. Neoplasia , 1979 .

[58]  K. Rothman,et al.  Replacement estrogens and endometrial cancer. , 1979, The New England journal of medicine.

[59]  P. Stolley,et al.  Endometrial cancer and estrogen use. Report of a large case-control study. , 1979, The New England journal of medicine.

[60]  A. Feinstein,et al.  Alternative Analytic Methods for Case-Control Studies of Estrogens and Endometrial Cancer , 1978 .

[61]  J. Crowley,et al.  Estrogen use - risk of endometrial carcinoma. , 1978, Gynecologic oncology.

[62]  J. Reagan,et al.  Estrogen and endometrial carcinoma. An independent pathology review supporting original risk estimate. , 1977, The New England journal of medicine.

[63]  R. Scully.  Estrogens and endometrial carcinoma. , 1977, Human pathology.

[64]  W. O'Fallon,et al.  Exogenous estrogen and endometrial carcinoma: case-control and incidence study. , 1977, American journal of obstetrics and gynecology.

[65]  M. Pike,et al.  Estrogens and endometrial cancer in a retirement community. , 1976, The New England journal of medicine.

[66]  R. Hoover,et al.  CANCER OF THE UTERINE CORPUS AFTER HORMONAL TREATMENT FOR BREAST CANCER , 1976, The Lancet.

[67]  D. Thompson,et al.  Association of exogenous estrogen and endometrial carcinoma. , 1975, The New England journal of medicine.

[68]  H. Ziel,et al.  Increased risk of endometrial carcinoma among users of conjugated estrogens. , 1975, The New England journal of medicine.